Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours

1. These authors jointly supervised this work: Kathrin Klar, Eugen Leo

Authors and Affiliations

1. Clínica Universidad de Navarra, CIMA, IDISNA and CIBERONC, Pamplona, Spain

   Ignacio Melero

2. Nuffield Department of Medicine, University of Oxford, Oxford, UK

   Ignacio Melero

3. START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain

   Maria de Miguel Luken, Emiliano Calvo & Irene Moreno

4. Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain

   Guillermo de Velasco, Jorge Esteban-Villarrubia & Javier Torres-Jiménez

5. Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Barcelona, Spain

   Elena Garralda, Arjun Oberoi & Alberto Hernando-Calvo

6. Medical Oncology, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Spain

   Juan Martín-Liberal, Paula Sabat & Juan José Soto-Castillo

7. Department of Medical Oncology & Hematology, Cantonal Hospital, St Gallen, Switzerland

   Markus Joerger, Kira-Lee Koster & Dagmar Hess

8. NEXT Oncology Phase I Unit/IOB - Hospital Quirónsalud Barcelona, Barcelona, Spain

   Guzman Alonso, Omar Saavedra & Fabricio Racca

9. Medizinische Klinik 2, Early Clinical Trial Unit, University Hospital Würzburg, Würzburg, Germany

   Maria-Elisabeth Goebeler & Cyrus Sayehli

10. West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany

    Martin Schuler, Tanja Gromke & Heike Richly

11. National Center for Tumor Diseases (NCT) West, Essen, Germany

    Martin Schuler, Tanja Gromke & Heike Richly

12. Department of Medical Oncology, University Hospital Basel, Basel, Switzerland

    David König, Heinz Läubli & Andreas M. Schmitt

13. Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

    Reinhard Dummer, Egle Ramelyte & Corinne Eggenschwiler

14. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) & Liver Oncology Unit, Liver Unit, Hospital Clínic, Barcelona, Spain

    Maria Reig, Marta Fortuny & Marco Sanduzzi-Zamparelli

15. Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain

    Maria Reig, Marta Fortuny & Marco Sanduzzi-Zamparelli

16. Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain

    Maria-Esperanza Rodriguez Ruiz, Ana Landa-Magdalena & Anna Vilalta-Lacarra

17. Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany

    Jörg Trojan & Christine Koch

18. Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

    Peter R. Galle & Friedrich Foerster

19. Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria

    Zlatko Trajanoski, Hubert Hackl & Falk Gogolla

20. Department of Urology, Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany

    Florestan J. Koll & Felix Kyoung Hwan Chun

21. Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany

    Peter Wild & Henning Reis

22. KinDyn Consulting, Warnham, UK

    Peter Lloyd

23. LYO-X AG, Basel, Switzerland

    Matthias Machacek

24. The University of Chicago Medical Center, Chicago, IL, USA

    Thomas F. Gajewski

25. Centre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université Paris Cité, Paris, France

    Wolf H. Fridman

26. University Medical Center Utrecht and Princess Máxima Center, Utrecht, The Netherlands

    Alexander M. M. Eggermont

27. Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig-Maximilian University, Munich, Germany

    Alexander M. M. Eggermont

28. Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany

    Ralf Bargou

29. Discovery Life Sciences Biomarker Services, Kassel, Germany

    Sandra Schöniger, Josef Rüschoff & Anastasiia Tereshchenko

30. Metronomia Clinical Research, Munich, Germany

    Carina Zink

31. da Silva Consulting Services, Munich, Germany

    Antonio da Silva

32. CatalYm, Munich, Germany

    Felix S. Lichtenegger, Julia Akdemir, Manfred Rüdiger, Phil L’Huillier, Aradhana Dutta, Markus Haake, Alexandra Auckenthaler, Ana Gjorgjioska, Bernhard Rössler, Frank Hermann, Mara Liebig, Daniela Reichhardt, Christine Schuberth-Wagner, Petra Fettes, Marlene Auer, Kathrin Klar & Eugen Leo

33. Department of Gynecology, University Hospital Würzburg, Würzburg, Germany

    Jörg Wischhusen

Corresponding authors

Correspondence to Ignacio Melero or Eugen Leo.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions